A carregar...

Anti-Thymocyte Globulin versus Interleukin-2 Receptor Antagonist in Kidney Transplant Recipients with Hepatitis C Virus

BACKGROUND: Hepatitis C virus-positive (HCV+) kidney transplant (KT) recipients are at increased risks of rejection and graft failure. The optimal induction agent for this population remains controversial, particularly regarding concerns that anti-thymocyte globulin (ATG) might increase HCV-related...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Transplantation
Main Authors: Bae, Sunjae, Durand, Christine M., Garonzik-Wang, Jacqueline M., Chow, Eric K. H., Kucirka, Lauren M., McAdams-DeMarco, Mara A., Massie, Allan B., Al Ammary, Fawaz, Coresh, Josef, Segev, Dorry L.
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7534413/
https://ncbi.nlm.nih.gov/pubmed/32433232
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/TP.0000000000002959
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!